PIK3CA and breast neoplasm: Based on these observations, our work aimed to study a putative role of the PI3K p110δ in breast tumour progression providing new guidance for a potentially beneficial use of p110δ-selective inhibitors alone or in combination with inhibitors of other components of PI3K pathway.